
Baxter International Inc. (NYSE:BAX) is down 19.4% at $22.66 at the last check on Thursday. At around 11 a.m. EST, shares of the medical device company traded at $21.68—just shy of its 52-week low.
Baxter reported a second-quarter adjusted EPS of 59 cents. That’s inline with the management guidance of 59-63 cents and the Wall Street estimate of 61 cents.